Frequently asked questions
The cancers included on this website are:
All malignant cancers excluding non-melanoma skin cancer (NMSC) (ICD-10 code - C00-C43 & C45-C97)
Bladder (Malignant neoplasm of bladder - ICD-10 code - C67)
Colorectal (bowel) cancer (Malignant neoplasm of colon, rectosigmoid junction and rectum - ICD-10 code - C18-C20)
Brain and other CNS
Brain and other CNS (Malignant neoplasm of meninges, brain, spinal cord, cranial nerves and other parts of central nervous system, pituitary gland, craniopharyngeal duct and pineal gland - ICD-10 code - C70-C72, C75)
For prevalence, this only covers Malignant neoplasm of meninges, neoplasm of brain and neoplasm of spinal cord, cranial nerves and other parts of central nervous system- ICD-10 code C70-C72
Breast (Female breast)
Breast (Malignant neoplasm of breast - ICD-10 code - C50)
Cervical (Malignant neoplasm of cervix uteri - ICD-10 code - C53)
Head and neck
Head and neck (Malignant neoplasm of lip, base of tongue, other and unspecified parts of tongue, gum, floor of mouth, palate, other and unspecified parts of mouth, parotid gland, other and unspecified major salivary glands, tonsil, oropharynx, nasopharynx, pyriform sinus, hypopharynx, other and ill-defined sites in the lip, oral cavity and pharynx, nasal cavity and middle ear, accessory sinuses and larynx - ICD-10 code - C00-C14, C30-C32)
Kidney (Malignant neoplasm of kidney, renal pelvis, ureter, other and unspecified urinary organs - ICD-10 code - C64-C66,C68)
Leukaemia (Lymphoid leukaemia, Myeloid leukaemiaI, Monocytic leukaemia, Other leukaemias of specified cell type and Leukaemia of unspecified cell type - ICD-10 code - C91-C95)
Liver (Malignant neoplasm of liver and intrahepatic bile ducts - ICD-10 code - C22)
Lung, trachea and bronchus
Lung (Malignant neoplasm of trachea bronchus and lung ICD-10 code - C33-C34)
Lymphoma (Hodgkin's disease and Non-Hodgkin's lymphoma, ICD-10 code - C81-C85)
Malignant melanoma (Malignant melanoma of skin - ICD-10 code - C43)
Multiple myeloma (Multiple myeloma and malignant plasma cell neoplasms - ICD-10 code - C90)
Oesophagus (Malignant neoplasm of oesophagus - ICD-10 code - C15)
Ovarian (Malignant neoplasm of ovary - ICD-10 code - C56)
Pancreas (Malignant neoplasm of pancreas - ICD-10 code - C25)
Prostate (Malignant neoplasm of prostate - ICD-10 code - C61)
Stomach (Malignant neoplasm of stomach - ICD-10 code - C16)
Testis (Malignant neoplasm of testis - ICD-10 code - C62)
Unknown primary (Malignant neoplasm of other and ill-defined sites, secondary and unspecified malignant neoplasm of lymph nodes, secondary malignant neoplasm of respiratory and digestive organs, secondary malignant neoplasm of other sites and malignant neoplasm without specification of site ICD-10 code - C77-C80)
Uterus (Malignant neoplasm of corpus uteri and uterus, part unspecified ICD-10 code - C54-C55)
Not all cancer types are represented within the tool for all data sets, as we have focused on a selection of common and rarer cancers where available.
On the charts, we had to exclude small numbers in order to maintain the privacy of the cancer patients behind the figures.
Clinical Commissioning Groups are NHS organisations set up by the Health and Social Care Act 2012 to organise the delivery of NHS services in England. They are clinically led groups that include all the general practice groups in their geographical area.
The aim of this is to give GPs and other clinicians the power to influence commissioning decisions for their patients'. CCGs' are overseen by NHS England.
These structures will manage primary care commissioning, including holding the NHS contracts for GP Practices NHS. CCGs' have boundaries that are concurrent with those of lower layer super output areas.
Data presented here is for the 207 CCG boundaries correct as of January 2018.
Source: Definitions of CCG taken from the Office for National Statistics. English Health Geography (accessed August 2015).
Cancer Alliances have been set up to bring together local senior clinical and managerial leaders representing the whole cancer patient pathway across a specific geography.
Together with the National Cancer Vanguard, they will lead the local delivery of the Independent Cancer Taskforce’s ambitions for improving services, care and outcomes for everyone with cancer.
For further information on Cancer Alliances, go to Macmillan's report (2015), 'Cancer Alliances: A Crucial First Step [PDF]'.
Data presented on this tool, is based on Clinical Commissioning Groups (CCGs) and Cancer Alliances / National Cancer Vanguards boundaries as of 14 February 2017, as defined by the Office for National Statistics (ONS).
For the purposes of this tool we have allocated NHS Cumbria to North East and Cumbria Cancer Alliance.
Source: Definition of Cancer Alliance taken from NHS England (accessed February 2017).
The majority of the indicators which are presented in the tool by CCG (prevalence, incidence, mortality) or by Cancer Alliance, are reported based on patients' postcode of residence at the time of their cancer diagnosis.
This website is best viewed using a desktop PC or Mac, with one of the following desktop web browsers.
- Internet Explorer browser versions 11 or higher
- Microsoft Edge
- Mozilla Firefox
- Safari 8
Please note, the LCI website may work and appear differently, dependent on the browser and device you are viewing it on. If you experience any issues, please contact us.
Yes, this website has been designed to work on mobile and tablet devices. It is best viewed on the following mobile browsers:
- iOS 9, 10
- Latest Android
The LCI website has a responsive design to maximise its usability across a variety of browsers and devices, however if you experience any issues, please contact us.
The Highcharts library, which is used for the charts for this website works well across multiple devices and screen sizes.
The charts will resize to fit the space available automatically on a device, but by their nature, most charts will not look great squeezed up on a small screen of a mobile device which is why we advise using a PC or Mac desktop web browser to view this website.
Each of the charts included on the tool has an icon at the top right. By clicking on this, you will be given the option to ‘print or view the data’ in various formats.
If you experience any issues with downloading data from the site, please contact us.
All pages on this website aim to conform to level AA of the Web Content Accessibility Guidelines 2.0. These guidelines are the internationally recognised benchmark for building accessible websites.
Macmillan Cancer Support websites are regularly audited by Nomensa and we are working to implement this standard on our other websites. If you'd like more information about this plus some useful tips on accessibility please visit the Macmillan accessibility page.
Please contact us if you are encountering any accessibility issues.